Cargando…
Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depres...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987189/ https://www.ncbi.nlm.nih.gov/pubmed/24741192 http://dx.doi.org/10.4103/0253-7613.129316 |
_version_ | 1782479636647641088 |
---|---|
author | Bhatt, Shvetank Radhakrishnan, Mahesh Jindal, Ankur Devadoss, Thangaraj Dhar, Arghya Kusum |
author_facet | Bhatt, Shvetank Radhakrishnan, Mahesh Jindal, Ankur Devadoss, Thangaraj Dhar, Arghya Kusum |
author_sort | Bhatt, Shvetank |
collection | PubMed |
description | AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to human depression, and such animal models can be used for the preclinical evaluation of antidepressants. MATERIALS AND METHODS: In the present study, a novel and potential 5-HT(3) receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) with good Log P (3.08) value and pA(2)(7.5) values, synthesized in our laboratory was investigated to study the effects on chronic unpredictable mild stress (CUMS)-induced behavioural and biochemical alterations in mice. Mice were subjected to different stress paradigms daily for a period of 28 days to induce depressive-like behaviour. RESULTS: The results showed that CUMS caused depression-like behaviour in mice, as indicated by the significant (P < 0.05) decrease in sucrose consumption and locomotor activity and increase in immobility the forced swim test. In addition, it was found that lipid peroxidation and nitrite levels were significantly (P < 0.05) increased, whereas glutathione levels, superoxide dismutase and catalase activities decreased in brain tissue of CUMS-treated mice. ‘6g’ (1 and 2 mg/kg, p.o., 21 days) and fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly (P < 0.05) reversed the CUMS-induced behavioural (increased immobility period, reduced sucrose preference and decreased locomotor activity) and biochemical (increased lipid peroxidation; decreased glutathione levels, superoxide dismutase and catalase activities). However fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly decreased the nitrite level in the brain while ‘6g’ (1 and 2 mg/kg, p.o., 21 days) did not show significant (P < 0.05) effect on the nitrite levels in brain. CONCLUSION: Compound ‘6g’ exerted antidepressant-like effects in behavioural despair paradigm in chronically stressed mice by restoring antioxidant mechanisms. |
format | Online Article Text |
id | pubmed-3987189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39871892014-04-16 Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice Bhatt, Shvetank Radhakrishnan, Mahesh Jindal, Ankur Devadoss, Thangaraj Dhar, Arghya Kusum Indian J Pharmacol Research Article AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to human depression, and such animal models can be used for the preclinical evaluation of antidepressants. MATERIALS AND METHODS: In the present study, a novel and potential 5-HT(3) receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) with good Log P (3.08) value and pA(2)(7.5) values, synthesized in our laboratory was investigated to study the effects on chronic unpredictable mild stress (CUMS)-induced behavioural and biochemical alterations in mice. Mice were subjected to different stress paradigms daily for a period of 28 days to induce depressive-like behaviour. RESULTS: The results showed that CUMS caused depression-like behaviour in mice, as indicated by the significant (P < 0.05) decrease in sucrose consumption and locomotor activity and increase in immobility the forced swim test. In addition, it was found that lipid peroxidation and nitrite levels were significantly (P < 0.05) increased, whereas glutathione levels, superoxide dismutase and catalase activities decreased in brain tissue of CUMS-treated mice. ‘6g’ (1 and 2 mg/kg, p.o., 21 days) and fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly (P < 0.05) reversed the CUMS-induced behavioural (increased immobility period, reduced sucrose preference and decreased locomotor activity) and biochemical (increased lipid peroxidation; decreased glutathione levels, superoxide dismutase and catalase activities). However fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly decreased the nitrite level in the brain while ‘6g’ (1 and 2 mg/kg, p.o., 21 days) did not show significant (P < 0.05) effect on the nitrite levels in brain. CONCLUSION: Compound ‘6g’ exerted antidepressant-like effects in behavioural despair paradigm in chronically stressed mice by restoring antioxidant mechanisms. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3987189/ /pubmed/24741192 http://dx.doi.org/10.4103/0253-7613.129316 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bhatt, Shvetank Radhakrishnan, Mahesh Jindal, Ankur Devadoss, Thangaraj Dhar, Arghya Kusum Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title | Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title_full | Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title_fullStr | Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title_full_unstemmed | Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title_short | Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
title_sort | neuropharmacological evaluation of a novel 5-ht(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987189/ https://www.ncbi.nlm.nih.gov/pubmed/24741192 http://dx.doi.org/10.4103/0253-7613.129316 |
work_keys_str_mv | AT bhattshvetank neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice AT radhakrishnanmahesh neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice AT jindalankur neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice AT devadossthangaraj neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice AT dhararghyakusum neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice |